Sagility544282Quarterly results

Board approves Q2 and H1 results, declares ₹0.15 interim dividend

Sagility's board on October 22, 2026 approved the unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026, and declared an interim dividend.

By ScoutQuest · Thu 22 Oct 2026, 6:24 PM IST · 2 min read

Consolidated · ₹ million · EPS in ₹
Line item	Latest	Year ago	YoY	Prev qtr	QoQ
Revenue from operations	20,320.97	16,584.99	+22.5%	19,634.83	+3.5%
Total income	20,449.45	17,166.64	+19.1%	19,778.06	+3.4%
Profit before tax	3,742.21	3,268.07	+14.5%	2,874.78	+30.2%
Profit after tax	2,842.12	2,508.26	+13.3%	2,168.11	+31.1%
Total comprehensive income	3,468.57	3,955.93	−12.3%	2,614.10	+32.7%
Basic EPS	0.61	0.53	+15.1%	0.46	+32.6%

Total income YoY growth: +19.1%
Period: Quarter ended 30 September 2026

Also decided at the meeting

Declared an interim dividend of ₹0.15/- per equity share (face value ₹10/- each) for FY 2026–27; record date October 30, 2026; to be paid on or before November 21, 2026 (outflow approx. Rs.702.20 million).

Auditor's review

Conclusion: Unmodified

Notes to the results

Exceptional item: past service cost of Rs.150.89 million on re-measurement of gratuity and leave encashment (revised minimum wages, New Labour Codes) recognised in quarter ended 30 June 2026.
On 11 June 2026 Sagility LLC acquired 100% of CareSeed LLC; provisional purchase consideration USD 21.2 million (Rs. 2,032.51 million); goodwill Rs. 1,507.58 million.
Subsequent event: on 21 October 2026 Sagility (US) Holdings Inc. agreed to acquire 100% of Chirok Health LLC for US$32.35 million (Rs. 3,102.44 million); not yet consummated.
Final dividend of Rs.0.10 per equity share for FY ended 31 March 2026 approved at AGM on 20 August 2026 and paid during the quarter.

Results at a glance

Sagility's board approved unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The consolidated numbers below are stated in Rs. in millions.

Revenue from operations for the quarter: Rs. 20,320.97 million, against Rs. 16,584.99 million in the same quarter a year earlier.
Profit for the period for the quarter: Rs. 2,842.12 million.

Auditor's conclusion

B S R & Co. LLP carried out a limited review of both the standalone and the consolidated statements and issued an unmodified conclusion — nothing came to their attention that caused them to believe the statements contain a material misstatement. A limited review is narrower in scope than a full audit and is not an audit opinion.

Dividend decision

Interim dividend of ₹0.15/- per equity share of face value ₹10/- each for the financial year 2026-27.
Record date: October 30, 2026. Payment on or before November 21, 2026.
The payout is expected to result in a cash outflow of approximately Rs. 702.20 million.

Acquisition completed during the period

On June 11, 2026 the group, through its wholly owned subsidiary Sagility LLC, acquired 100% of the equity interest in CareSeed LLC, a US-based healthcare technology company providing quality measurement reporting and risk adjustment solutions for health plans. The total contractual consideration was Rs. 2,873.38 million, including contingent consideration linked to specified performance targets over three years.

Agreement signed after the quarter

On October 21, 2026 the group, through Sagility (US) Holdings Inc., entered a definitive agreement with Chirok Health LLC to acquire 100% of its equity shares for a total consideration of up to Rs. 3,102.44 million, including contingent consideration linked to achievement of specified performance targets. Chirok is a US-based healthcare services company specialising in clinical documentation integrity, medical coding, revenue cycle management and audit and quality assurance services. As of the date of board approval, the closing conditions have not been met and hence the transaction has not been consummated.

What a retail investor can take away

The update combines three things: reviewed quarterly numbers, a cash dividend with clear record and payment dates, and disclosure of an acquisition completed and another agreed but not yet closed.
The dividend is small per share but the total payout is quantified, so the cash leaving the company can be judged directly.
The auditor's conclusion is unmodified, which is the standard clean outcome for a limited review.

20,449.45 (Rs. in millions)Total income, latest quarter

Total income, year-ago quarter17,166.64 (Rs. in millions)

Total comprehensive income, latest quarter3,468.57 (Rs. in millions)

Total income, latest quarter 20,449.45 (Rs. in millions): Total income, year-ago quarter 17,166.64 (Rs. in millions), Total comprehensive income, latest quarter 3,468.57 (Rs. in millions).

Also from Sagility